Negative hyperselection and mechanisms of acquired resistance to first-line chemotherapy plus anti-EGFR in patients (pts) with pMMR RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC): A translational analysis of the TRIPLETE trial.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Veronica Conca, Martina Carullo, Paola Vignali, Daniele Rossini, Marco Maria Germani, Francesca Bergamo, Filippo Pietrantonio, Beatrice Borelli, Federica Marmorino, Mirella Giordano, Giovanni Randon, Ada Taravella, Riccardo Cerantola, Alessandro Cappetta, Angela Buonadonna, Alberto Zaniboni, Lorenzo Antonuzzo, Gianluca Masi, Clara Ugolini, Chiara Cremolini
Institutions: University of Pisa, Azienda Ospedaliera Universitaria Pisana, University of Florence, Istituto Oncologico Veneto, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda Ospedaliero-Universitaria Careggi, University of Padua, Ospedale San Bortolo, Centro di Riferimento Oncologico, Fondazione Poliambulanza Istituto Ospedaliero
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Regione Toscana
OpenAlex ID: W4400108860